| |
Cancer Genetic Markers of Susceptibility Project
 |
The Cancer Genetic Markers of Susceptibility (CGEMS) is a three-year,
$14 million initiative that will identify genetic alterations that make people susceptible to prostate and breast cancer. Scientists involved will use DNA available from five large studies of prostate cancer and five large studies of breast cancer to “scan” the genome for common genetic variations between patients who have these cancers and controls who do not have cancer.
Learn more >>
|
 |
Background
 |
To help eliminate suffering and death due to cancer, the National Cancer Institute is capitalizing on the momentum generated by advances in human genetic research. The tools and information coming out of the Human Genome Project and the International HapMap Project facilitate the investigation of the genetic contribution to different types of cancer. This NCI Strategic Initiative will be coordinated through the Division of Cancer Epidemiology and Genetics (DCEG), the NCI Core Genotyping Facility (CGF), and the NCI Office of Cancer Genomics (OCG).
Learn more >>
|
|
|
|
|
